Summit Therapeutics (NASDAQ: SMMT) 30-day option implied volatility is at 90; compared to its 52-week range of 70 to 146. Call put ratio 6.3 calls to 1 put with a focus on a spreader of 2K contracts of June 25 and 30 calls as share price up 13.6%.